Gene Therapy for X-Linked Retinitis Pigmentosa
Retina Synthesis - A podcast by Retina Synthesis
Categories:
We discuss the latest information on phase 2 trials of gene therapy for x-linked retinitis pigmentosa with Dr. Nadia Waheed, Chief Medical Officer of Beacon Therapeutics and Associate Professor of Ophthalmology at the New England Eye Center, Tufts University School of Medicine.
